Maraldi Tullia, Riccio Massimo, Pisciotta Alessandra, Zavatti Manuela, Carnevale Gianluca, Beretti Francesca, La Sala Giovanni B, Motta Antonella, De Pol Anto
Stem Cell Res Ther. 2013 May 21;4(3):53. doi: 10.1186/scrt203.
The main aim of this study is to evaluate potential human stem cells, such as dental pulp stem cells and amniotic fluid stem cells, combined with collagen scaffold to reconstruct critical-size cranial bone defects in an animal model.
We performed two symmetric full-thickness cranial defects on each parietal region of rats and we replenished them with collagen scaffolds with or without stem cells already seeded into and addressed towards osteogenic lineage in vitro. After 4 and 8 weeks, cranial tissue samples were taken for histological and immunofluorescence analysis.
We observed a new bone formation in all of the samples but the most relevant differences in defect correction were shown by stem cell-collagen samples 4 weeks after implant, suggesting a faster regeneration ability of the combined constructs. The presence of human cells in the newly formed bone was confirmed by confocal analysis with an antibody directed to a human mitochondrial protein. Furthermore, human cells were found to be an essential part of new vessel formation in the scaffold.
These data confirmed the strong potential of bioengineered constructs of stem cell-collagen scaffold for correcting large cranial defects in an animal model and highlighting the role of stem cells in neovascularization during skeletal defect reconstruction.
本研究的主要目的是评估潜在的人类干细胞,如牙髓干细胞和羊水干细胞,与胶原蛋白支架相结合,在动物模型中修复临界大小的颅骨缺损。
我们在大鼠的每个顶叶区域制造两个对称的全层颅骨缺损,并使用已接种并在体外诱导向成骨谱系分化的干细胞或未接种干细胞的胶原蛋白支架进行填充。4周和8周后,采集颅骨组织样本进行组织学和免疫荧光分析。
我们在所有样本中均观察到新骨形成,但植入后4周时,干细胞-胶原蛋白样本在缺损修复方面表现出最显著的差异,表明组合构建体具有更快的再生能力。通过针对人类线粒体蛋白的抗体进行共聚焦分析,证实了新形成骨中存在人类细胞。此外,发现人类细胞是支架中新血管形成的重要组成部分。
这些数据证实了干细胞-胶原蛋白支架生物工程构建体在动物模型中修复大型颅骨缺损的强大潜力,并突出了干细胞在骨骼缺损重建过程中新生血管形成中的作用。